Strategikon Announces Clinical Maestro 2.4
Strategikon Pharma announced a major update to their Clinical Maestro platform including features that target clinical trial planning and sourcing. This release, Clinical Maestro CORETM, focuses on expanding the ease of use and flexibility for Contract Research Organizations and other clinical service providers who need to quickly create accurate bids.
Clinical Maestro CORE is a configurable, cloud-based SaaS solution combining clinical study and services assumptions with complex costing algorithms that aim to produce clinical study budgets faster and more reliably than traditional Excel-based methods.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
